tiprankstipranks
Ascendis Pharma’s TransCon hGH Receives FDA Review for Adult Use
PremiumCompany AnnouncementsAscendis Pharma’s TransCon hGH Receives FDA Review for Adult Use
8d ago
Ascendis Pharma announces FDA to review TransCon hGH sBLA
Premium
The Fly
Ascendis Pharma announces FDA to review TransCon hGH sBLA
8d ago
Ascendis Pharma Reviews Share Structure and Capital Strategy
Premium
Company Announcements
Ascendis Pharma Reviews Share Structure and Capital Strategy
9d ago
Ascendis Pharma Reports Revenue Growth Despite Loss
PremiumCompany AnnouncementsAscendis Pharma Reports Revenue Growth Despite Loss
1M ago
Ascendis Pharma’s Q3 Growth and Strategic Moves
Premium
Company Announcements
Ascendis Pharma’s Q3 Growth and Strategic Moves
1M ago
Ascendis Pharma reports Q3 EPS (EUR 1.72) vs. (EUR 2.88) last year
Premium
The Fly
Ascendis Pharma reports Q3 EPS (EUR 1.72) vs. (EUR 2.88) last year
1M ago
BioMarin price target lowered to $90 from $110 at Cantor Fitzgerald
PremiumThe FlyBioMarin price target lowered to $90 from $110 at Cantor Fitzgerald
2M ago
Ascendis Pharma price target lowered to $174 from $180 at JPMorgan
Premium
The Fly
Ascendis Pharma price target lowered to $174 from $180 at JPMorgan
2M ago
3 Best Stocks to Buy Now, 10/21/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 10/21/2024, According to Top Analysts 
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100